Microfluidization plays a crucial role in the development of liposomes, lipid nanoparticles (LNPs), nanoemulsions, and polymer-based drug delivery systems. This high-shear processing technology enables precise control over particle size, uniformity, and stability—key factors in optimizing therapeutic performance.
In this expert Q&A, Ardena’s nanomedicine specialists delve into how microfluidization compares to other nanoparticle production methods, its scalability for pharmaceutical manufacturing, and its ability to encapsulate sensitive biologics.
